These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10447400)

  • 21. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
    Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
    Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of the soluble isoforms of HLA-G.
    Hunt JS; Pace JL; Morales PJ; Ober C
    Mol Hum Reprod; 2003 Nov; 9(11):729-35. PubMed ID: 14561816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble HLA-G expression and renal graft acceptance.
    Qiu J; Terasaki PI; Miller J; Mizutani K; Cai J; Carosella ED
    Am J Transplant; 2006 Sep; 6(9):2152-6. PubMed ID: 16780545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
    Puppo F; Contini P; Ghio M; Indiveri F
    ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients.
    Ravindranath MH; Pham T; Ozawa M; Terasaki PI
    Int Immunol; 2012 Jan; 24(1):43-57. PubMed ID: 22190577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies.
    Regan J; Monteiro F; Speiser D; Kalil J; Pouletty P; Buelow R
    Am J Kidney Dis; 1996 Jul; 28(1):92-8. PubMed ID: 8712228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
    Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
    Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of HLA IgG antibodies by two enzyme-linked immunoassays, solubilized HLA class I and PRA-STAT. Comparison with the AHG PRA.
    Bryan CF; Baier KA; Flora-Ginter G; Shield CF; Warady BA; Aeder MI; Borkon AM; Estep TH; Forster J; Landreneau MD
    Transplantation; 1995 Dec; 60(12):1588-94. PubMed ID: 8545895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
    Schönemann C; Groth J; Leverenz S; May G
    Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection.
    Puppo F; Pellicci R; Brenci S; Nocera A; Morelli N; Dardano G; Bertocchi M; Antonucci A; Ghio M; Scudeletti M
    Hum Immunol; 1994 Jul; 40(3):166-70. PubMed ID: 7960957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical importance of choosing the right assay for detection of HLA-specific donor-reactive antibodies.
    Sumitran-Karuppan S
    Transplantation; 1999 Aug; 68(4):502-9. PubMed ID: 10480407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
    Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ
    Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation.
    Christiaans MH; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 2000 Mar; 69(5):917-27. PubMed ID: 10755551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay.
    Westhoff U; Thinnes FP; Götz H; Grosse-Wilde H
    Vox Sang; 1991; 61(2):106-10. PubMed ID: 1763495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Typing of a panel of soluble HLA class I antigens by enzyme-linked immunosorbent assay.
    Pouletty C; Mercier I; Glanville L; Tomavo N; Igoudin L; Pouletty P; Buelow R
    Hum Immunol; 1994 Jul; 40(3):218-27. PubMed ID: 7960966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble HLA class I molecules exert differentiated influence on renal graft condition.
    Chudyk A; Masiuk M; Myślak M; Domański L; Sieńko J; Sulikowski T; Machaliński B; Giedrys-Kalemba S
    Transplant Proc; 2006; 38(1):90-3. PubMed ID: 16504672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.
    Fainardi E; Rizzo R; Melchiorri L; Vaghi L; Castellazzi M; Marzola A; Govoni V; Paolino E; Tola MR; Granieri E; Baricordi OR
    J Neuroimmunol; 2003 Sep; 142(1-2):149-58. PubMed ID: 14512174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble HLA antigens and ELISA--a new technology for crossmatch testing.
    Buelow R; Chiang TR; Monteiro F; Cornejo MC; Ellingson L; Claas F; Gaber O; Gelder F; Kotb M; Orosz C
    Transplantation; 1995 Dec; 60(12):1594-9. PubMed ID: 8545896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.